Age-standardized rates of incidence, mortality and DALYs for AYAs with gastric cancer in 1990 and 2021 for both sexes in 21 GBD regions. حسب Mengjia Zhu (15469202)

الموضوعات:

Age-standardized rates of incidence, mortality and DALYs for AYAs with colorectal cancer in 1990 and 2021 for both sexes in 21 GBD regions. حسب Mengjia Zhu (15469202)

الموضوعات:

Age-standardized rates of incidence, mortality and DALYs for AYAs with liver cancer in 1990 and 2021 for both sexes in 21 GBD regions. حسب Mengjia Zhu (15469202)

الموضوعات:

Age-standardized rates of incidence, mortality and DALYs for AYAs with esophageal cancer in 1990 and 2021 for both sexes in 21 GBD regions. حسب Mengjia Zhu (15469202)

الموضوعات:

Age-standardized rates of incidence, mortality and DALYs for AYAs with pancreatic cancer in 1990 and 2021 for both sexes in 21 GBD regions. حسب Mengjia Zhu (15469202)

الموضوعات:

Global disease burden of NAFLD in males and females by different age group in 2021. حسب Yuqin Mao (9937788)

Incidence, ASIR, and Relative change of Tuberculosis in children and Adolescence in global and 21 regions, with EAPC from 1990 and 2021. حسب Xue Li (285380)

الموضوعات:

BMI groups by SES. حسب Krystal Hunter (6820052)

"…For every increase in BMI, there was a decrease in the probability of PTB (OR = 0.923, 95% CI 0.915–0.931, P < 0.001). …"

Diagram of study population. حسب Krystal Hunter (6820052)

"…For every increase in BMI, there was a decrease in the probability of PTB (OR = 0.923, 95% CI 0.915–0.931, P < 0.001). …"

<i>IR52a</i>^<i>+</i> neurons synapse with sexually dimorphic second-order neurons. حسب Zhe He (508742)

Data Sheet 1_Global, regional, and national burdens of PUD in women of reproductive age from 1992 to 2021: a trend analysis based on the global burden of disease study 2021.csv حسب Xiaofeng Wang (119575)

"…</p>Results<p>In 2021, the global age-standardized incidence rates (ASIR) and death rates (ASDR) for PUD among WCBA were 24.18 per 100,000 (95% CI: 14.72–36.38) and 0.54 per 100,000 (95% CI: 0.42–0.66), respectively. …"

Data Sheet 4_Global, regional, and national burdens of PUD in women of reproductive age from 1992 to 2021: a trend analysis based on the global burden of disease study 2021.csv حسب Xiaofeng Wang (119575)

"…</p>Results<p>In 2021, the global age-standardized incidence rates (ASIR) and death rates (ASDR) for PUD among WCBA were 24.18 per 100,000 (95% CI: 14.72–36.38) and 0.54 per 100,000 (95% CI: 0.42–0.66), respectively. …"

Data Sheet 3_Global, regional, and national burdens of PUD in women of reproductive age from 1992 to 2021: a trend analysis based on the global burden of disease study 2021.csv حسب Xiaofeng Wang (119575)

"…</p>Results<p>In 2021, the global age-standardized incidence rates (ASIR) and death rates (ASDR) for PUD among WCBA were 24.18 per 100,000 (95% CI: 14.72–36.38) and 0.54 per 100,000 (95% CI: 0.42–0.66), respectively. …"

Data Sheet 2_Global, regional, and national burdens of PUD in women of reproductive age from 1992 to 2021: a trend analysis based on the global burden of disease study 2021.csv حسب Xiaofeng Wang (119575)

"…</p>Results<p>In 2021, the global age-standardized incidence rates (ASIR) and death rates (ASDR) for PUD among WCBA were 24.18 per 100,000 (95% CI: 14.72–36.38) and 0.54 per 100,000 (95% CI: 0.42–0.66), respectively. …"

Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in global men and women, 1990–2021. حسب Zhengpeng Li (2322058)

الموضوعات:

The number of incidence cases and the ASIR of Polycystic Ovary Syndrome in 1990 and 2021, and its temporal trends from 1990 to 2021. حسب Huanghui Qin (22057266)

All–age cases and age–standardised incidence, prevalence, mortality, DALYs and corresponding AAPC for RA in China and world in 1990 and 2021. حسب Zhengpeng Li (2322058)

الموضوعات:

Second. حسب Cuicui Liu (1496260)

Projections of Gastric Cancer Incidence and Mortality Burden in Taiwan Through 2036. حسب Xiaohuang Yang (10182727)

الموضوعات:

Individual salivary IgA and IgG titers. حسب Kenny Nguyen (7361624)

"…In contrast to IgA titers, IgG antibody titers increased substantially 2 weeks after the first vaccine dose, peaked 2 weeks after the second dose and persisted at an elevated level until at least 8 weeks after the first vaccine dose. …"